Stock Price
264.32
Daily Change
10.88 4.29%
Monthly
21.66%
Yearly
2.29%
Q4 Forecast
258.37

EPS Reference Time Actual Consensus Previous
2026-11-04 FY2026Q2 PM 2.94 2.69 2.47
2026-08-05 FY2026Q1 PM 2.59 2.50 2.34
2026-05-11 FY2026Q4 PM 2.83 2.86 2.74
2026-02-04 FY2026Q3 PM 2.53 2.53 2.32
2025-11-05 FY2026Q2 PM 2.47 2.36 2.14



Peers Price Chg Day Year Date
Olympus 1,776.00 -14.50 -0.81% -15.67% Nov/13
Accuray 2.80 -0.28 -9.09% 169.23% Nov/13
Baxter International 25.81 0.07 0.27% 39.74% Nov/13
Becton, Dickinson and Co. 218.03 2.32 1.08% 12.95% Nov/13
Boston Scientific 44.34 0.14 0.32% -56.82% Nov/13
CONMED 50.59 0.11 0.22% 20.34% Nov/13
Cooper Companies 62.65 0.46 0.74% -13.14% Nov/13
Dexcom 83.33 1.94 2.38% 43.52% Nov/13
Ecolab 309.27 4.86 1.60% 19.60% Nov/13
Edwards Lifesciences 107.15 1.35 1.28% 24.16% Nov/13

Indexes Price Day Year Date
US Index 400 3682 -4.08 -0.11% 14.88% Nov/13
US Index 2000 2790 -8.57 -0.31% 16.84% Nov/13
US Index 500 7562 -30.72 -0.40% 12.29% Nov/13

Steris traded at $264.32 this Friday November 13th, increasing $10.88 or 4.29 percent since the previous trading session. Looking back, over the last four weeks, Steris gained 21.66 percent. Over the last 12 months, its price rose by 2.29 percent. Looking ahead, we forecast Steris to be priced at 258.37 by the end of this quarter and at 241.32 in one year, according to Trading Economics global macro models projections and analysts expectations.

Steris plc, formerly Steris Ltd, is a provider of infection prevention and other procedural products and services. The Company offers a mix of capital equipment products, such as sterilizers and washers, surgical tables, lights and equipment management systems and connectivity solutions, such as operating room integration; consumable products, such as detergents and gastrointestinal endoscopy accessories and other products; services, including equipment installation and maintenance, microbial reduction of medical devices, instrument and scope repair solutions, laboratory services and outsourced reprocessing. The Company operates through four reportable business segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. It’s Corporate and other segment includes the Defense and Industrial business unit. The Company serves the customers in the United Kingdom, the United States and many other countries throughout the world.